Education
Academic Background-
Ph.D. Taipei Medical University, Taiwan Medicine | Completed: 2019
Publications (3)
Selected Scholarly Contributions
Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α II bβ3 binding in human platelets.
Chih-Hsuan Hsia
2018
Novel iridium (III)‑derived organometallic compound for the inhibition of human platelet activation.
Chih-Hsuan Hsia
2018
Development of benzimidazole derivatives as novel anti-platelet drugs.
Chih-Hsuan Hsia
2017